EMA Sets Up Task Force To Offer Advice on Zika Research and Development
This article was originally published in SRA
Executive Summary
Following the announcement that the European Commission is to mobilize €10m for research into the mosquito-borne Zika virus, the European Medicines Agency has set up a dedicated expert task force to offer advice on R&D programs for medicines and vaccines, and is asking companies with potential projects to get in touch1.